相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of infliximab and tocilizumab on fructose-induced hyperinsulinemia and hypertension in rats
Aly M. Abdelrahman et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers
Natalia Ruggeri Barbaro et al.
BLOOD PRESSURE (2015)
Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension
Ana Paula Cabral de Faria et al.
CLINICA CHIMICA ACTA (2014)
Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients
S. Yoshida et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Role of tumour necrosis factor receptor-1 and nuclear factor-κB in production of TNF-α-induced pro-inflammatory microparticles in endothelial cells
Sung Kyul Lee et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women
Kerrie L. Moreau et al.
ATHEROSCLEROSIS (2013)
Infliximab prevents increased systolic blood pressure and upregulates the AKT/eNOS pathway in the aorta of spontaneously hypertensive rats
Ademir Gazzoto Filho et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure
Valeria Nasser Figueiredo et al.
BLOOD PRESSURE (2012)
Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
Kaisa M. Maeki-Petaejae et al.
CIRCULATION (2012)
Assessment of flow-mediated dilation in humans: a methodological and physiological guideline
Dick H. J. Thijssen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Jeffrey D. Greenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial
Naomi B. Klarenbeek et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Involvement of tumor necrosis factor-α in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy
Srinivas Sriramula et al.
HYPERTENSION (2008)
Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction
Tomasz J. Guzik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Stephane Laurent et al.
EUROPEAN HEART JOURNAL (2006)
Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-α therapy
Kaisa M. Maki-Petaja et al.
CIRCULATION (2006)
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab - Results from the ASPIRE trial
JS Smolen et al.
ARTHRITIS AND RHEUMATISM (2006)
Erythrocytes are the major intravascular storage sites of nitrite in human blood
A Dejam et al.
BLOOD (2005)
A phase II study of etanercept (enbrel), a tumor necrosis factor α inhibitor in patients with metastatic breast cancer
S Madhusudan et al.
CLINICAL CANCER RESEARCH (2004)
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma:: increase in plasma TNFα levels during treatment
AM Tsimberidou et al.
LEUKEMIA RESEARCH (2003)
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force
MC Corretti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Infliximab and methotrexate in the treatment of rheumatoid arthritis
PE Lipsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
